MedMira Inc (MIR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, MedMira Inc (MIR) has a cash flow conversion efficiency ratio of 0.011x as of January 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-267.69K ≈ $-193.64K USD) by net assets (CA$-24.03 Million ≈ $-17.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MIR equity financing ratio to measure how much of total assets are equity-financed.
MedMira Inc - Cash Flow Conversion Efficiency Trend (2000–2025)
This chart illustrates how MedMira Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check MedMira Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
MedMira Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of MedMira Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Otto Holding AS
IS:OTTO
|
0.053x |
|
Fancamp Exploration Ltd.
V:FNC
|
-0.014x |
|
SK Chemicals Co Ltd Pref
KO:28513K
|
0.016x |
|
Australian Mines Ltd
AU:AUZ
|
-0.017x |
|
Wiseway Group Ltd
AU:WWG
|
0.102x |
|
Allwin Telecommunication Co Ltd
SHE:002231
|
-0.069x |
|
Coda Minerals Ltd
AU:COD
|
-0.136x |
|
InspireMD Inc
NASDAQ:NSPR
|
-0.283x |
Annual Cash Flow Conversion Efficiency for MedMira Inc (2000–2025)
The table below shows the annual cash flow conversion efficiency of MedMira Inc from 2000 to 2025. For the full company profile with market capitalisation and key ratios, see MIR market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-07-31 | CA$-22.56 Million ≈ $-16.32 Million |
CA$-3.15 Million ≈ $-2.28 Million |
0.139x | -14.42% |
| 2024-07-31 | CA$-18.04 Million ≈ $-13.05 Million |
CA$-2.94 Million ≈ $-2.13 Million |
0.163x | +93.17% |
| 2023-07-31 | CA$-15.03 Million ≈ $-10.87 Million |
CA$-1.27 Million ≈ $-917.07K |
0.084x | -44.69% |
| 2022-07-31 | CA$-12.36 Million ≈ $-8.94 Million |
CA$-1.88 Million ≈ $-1.36 Million |
0.152x | +375.09% |
| 2021-07-31 | CA$-15.72 Million ≈ $-11.37 Million |
CA$-504.64K ≈ $-365.05K |
0.032x | +58.11% |
| 2020-07-31 | CA$-15.56 Million ≈ $-11.26 Million |
CA$-315.90K ≈ $-228.51K |
0.020x | -70.85% |
| 2019-07-31 | CA$-13.52 Million ≈ $-9.78 Million |
CA$-941.13K ≈ $-680.80K |
0.070x | -0.23% |
| 2018-07-31 | CA$-11.40 Million ≈ $-8.25 Million |
CA$-795.41K ≈ $-575.38K |
0.070x | -66.83% |
| 2017-07-31 | CA$-8.98 Million ≈ $-6.50 Million |
CA$-1.89 Million ≈ $-1.37 Million |
0.210x | -60.61% |
| 2016-07-31 | CA$-7.66 Million ≈ $-5.54 Million |
CA$-4.09 Million ≈ $-2.96 Million |
0.534x | +75.38% |
| 2015-07-31 | CA$-7.70 Million ≈ $-5.57 Million |
CA$-2.35 Million ≈ $-1.70 Million |
0.305x | -56.23% |
| 2014-07-31 | CA$-6.69 Million ≈ $-4.84 Million |
CA$-4.66 Million ≈ $-3.37 Million |
0.696x | +685.62% |
| 2011-07-31 | CA$-19.11 Million ≈ $-13.83 Million |
CA$-1.69 Million ≈ $-1.22 Million |
0.089x | -44.03% |
| 2010-07-31 | CA$-16.66 Million ≈ $-12.05 Million |
CA$-2.64 Million ≈ $-1.91 Million |
0.158x | +25.16% |
| 2009-07-31 | CA$-16.00 Million ≈ $-11.57 Million |
CA$-2.02 Million ≈ $-1.46 Million |
0.126x | -45.46% |
| 2008-07-31 | CA$-13.94 Million ≈ $-10.08 Million |
CA$-3.23 Million ≈ $-2.34 Million |
0.232x | +40.86% |
| 2007-07-31 | CA$-12.78 Million ≈ $-9.24 Million |
CA$-2.10 Million ≈ $-1.52 Million |
0.165x | -82.43% |
| 2006-07-31 | CA$-8.05 Million ≈ $-5.82 Million |
CA$-7.54 Million ≈ $-5.45 Million |
0.937x | +70.96% |
| 2005-07-31 | CA$-9.80 Million ≈ $-7.09 Million |
CA$-5.37 Million ≈ $-3.89 Million |
0.548x | +4.46% |
| 2004-07-31 | CA$-5.87 Million ≈ $-4.25 Million |
CA$-3.08 Million ≈ $-2.23 Million |
0.525x | -61.59% |
| 2003-07-31 | CA$-2.19 Million ≈ $-1.58 Million |
CA$-2.99 Million ≈ $-2.16 Million |
1.366x | +178.17% |
| 2002-07-31 | CA$-7.45 Million ≈ $-5.39 Million |
CA$-3.66 Million ≈ $-2.64 Million |
0.491x | -51.47% |
| 2001-07-31 | CA$-6.01 Million ≈ $-4.35 Million |
CA$-6.08 Million ≈ $-4.40 Million |
1.012x | +8.71% |
| 2000-07-31 | CA$-3.28 Million ≈ $-2.37 Million |
CA$-3.05 Million ≈ $-2.21 Million |
0.931x | -- |
About MedMira Inc
MedMira Inc., a biotechnology company, researches, develops, manufactures, and sells rapid diagnostics and technology platforms in North America, Europe, and internationally. The company offers Reveal HIV, a test that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or who… Read more